Erschienen in:
01.04.2020 | Original Article
Treatment of pulmonary arteriovenous malformations: clinical experience using different embolization strategies
verfasst von:
Akira Adachi, Kengo Ohta, Younes Jahangiri, Yusuke Matsui, Masahiro Horikawa, Yindee Geeratikun, Orapin Chansanti, Shinsaku Yata, Shinya Fujii, Jonathan Steinberger, Frederick S. Keller, Khashayar Farsad
Erschienen in:
Japanese Journal of Radiology
|
Ausgabe 4/2020
Einloggen, um Zugang zu erhalten
Abstract
Purpose
To evaluate embolization efficacy of pulmonary arteriovenous malformations (PAVM) using Amplatzer vascular plugs (AVP) and coils.
Materials and methods
Eighty-eight embolized simple PAVMs in 38 patients were retrospectively analyzed by follow-up CT. Mean age was 50.2 ± 15.6 years and 22 (57.9%) patients were females. Mean follow-up interval was 38.2 ± 28.4 months (median 29.9 months). Embolization devices included AVP I, AVP II, AVP 4, and coils. Technical success was defined as no visualization of an early draining vein at angiography after embolization. Treatment success was defined as complete disappearance or decrease in size of the venous aneurysm ≥ 70% at follow-up CT.
Results
Technical success rate was 100% and treatment success rate evaluated by CT for the various embolization strategies was 100% for AVP I (n = 6), 100% for AVP I + coils (n = 5), 83.3% for AVP II (n = 6), 40.0% for AVP II + coils (n = 5), 87.5% for AVP 4 (n = 8), 50.0% for AVP 4 + coils (n = 8), and 78.0% for coils alone (n = 50). No statistically significant difference in embolization efficacy was seen between different devices (P = 0.083). Although not statistically significant, combination use of coils with AVPs demonstrated lower rates of clinical embolization success (P = 0.053).
Conclusion
Embolization of PAVMs demonstrated high technical and treatment success rates with available embolic devices. No significant statistical differences were demonstrated between AVPs. However, the need for both coils and AVPs may suggest a more complicated underlying lesion at risk for recurrence.